This inventor holds 2 USPTO granted patents. Top assignees: Dcd Inc., Genomine, Inc.. Active years: 2011-2012.
Company Filing History:
2 out of 9 
2 out of 8 
Years Active: 2011-2012
Title: Mo Yoel Park: Innovator in Diagnostic Technologies
Introduction
Mo Yoel Park is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of diagnostics, particularly in the detection of renal cell carcinoma. With a total of two patents to his name, Park's work showcases his commitment to advancing medical technology.
Latest Patents
Park's latest patents include a diagnostic composition and kit for renal cell carcinoma. This innovative kit employs various markers such as nicotinamide N-methyltransferase, L-plastin, secretagogin, NM23A, CapG, and C4a anaphylatoxin to aid in the diagnosis of this serious condition. Additionally, he has developed a method and kit for isolating and fractioning phosphoproteins. This method utilizes specific metal ions to form complexes with phosphoproteins, allowing for easier precipitation with various precipitants.
Career Highlights
Throughout his career, Mo Yoel Park has worked with several companies, including DCD Inc. and Genomine, Inc. His experience in these organizations has contributed to his expertise in the field of diagnostics and biotechnology.
Collaborations
Park has collaborated with notable colleagues, including Dong Su Kim and Hyung Jin Na, who is a woman. These collaborations have likely enriched his research and development efforts.
Conclusion
Mo Yoel Park's contributions to diagnostic technologies, particularly in renal cell carcinoma, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a significant advancement in the field, showcasing the potential for better diagnostic methods.